Reduction in Adiposity, β-Cell Function, Insulin Sensitivity, and Cardiovascular Risk Factors: A Prospective Study among Japanese with Obesity

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Goto, Maki ^a,b,c   Morita, Akemi ^c,d   Goto, Atsushi ^a,b,c   Deura, Kijo ^e   Sasaki, Satoshi ^f   Aiba, Naomi ^g   Shimbo, Takuro ^a   Terauchi, Yasuo ^b   Miyachi, Motohiko ^c   Noda, Mitsuhiko ^a   Watanabe, Shaw ^c  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^d KOSHIEN UNIVERSITY   (Japan)

^e Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g KANAGAWA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SENSITIVITY INDEX; JAPANESE; LIPID BLOOD LEVEL; MALE; OBESITY; OBSERVATIONAL STUDY; PANCREAS ISLET BETA CELL; PROSPECTIVE STUDY; SUBCUTANEOUS FAT AREA; VISCERAL FAT AREA; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; JAPAN; LIPIDS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84874623546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057964     Document Type: Article

References (29)

1. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K, (1987) Central obesity and coronary heart disease in men. Lancet 1: 821-824.
2. Fujimoto WY, Leonetti DL, Bergstrom RW, Shuman WP, Wahl PW, (1990) Cigarette smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men. Am J Med 89: 761-771.
3. Look ARG, Wing RR, (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170: 1566-1575.
4. Carr DB, Utzschneider KM, Boyko EJ, Asberry PJ, Hull RL, et al. (2005) A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. Diabetes 54: 340-347.
5. Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, et al. (1992) Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41: 826-834.
6. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, et al. (2008) Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 57: 1269-1275.
7. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX, (1997) Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 46: 456-462.
8. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, et al. (2011) Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34: 1481-1486.
9. Matsushita Y, Nakagawa T, Yamamoto S, Takahashi Y, Yokoyama T, et al. (2012) Effect of longitudinal changes in visceral fat area and other anthropometric indices to the changes in metabolic risk factors in Japanese men: the Hitachi Health Study. Diabetes Care 35: 1139-1143.
10. Goncalves FB, Koek M, Verhagen HJ, Niessen WJ, Poldermans D, (2011) Body-mass index, abdominal adiposity, and cardiovascular risk. Lancet 378: 227; author reply 228.
11. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M,et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. The Lancet 373: 2215-2221.
12. Watanabe S, Morita A, Aiba N, Miyachi M, Sasaki S, et al. (2007) Study Design of the Saku Control Obesity Program (SCOP). Anti-Aging Medicine 4: 70-73.
13. Morita A, Ohmori Y, Suzuki N, Ide N, Morioka M, et al. (2008) Anthropometric and Clinical Findings in Obese Japanese: The Saku Control Obesity Program (SCOP). Anti-Aging Medicine 5: 13-16.
14. Tanaka T, Morita A, Kato M, Hirai T, Mizoue T, et al. (2011) Congener-specific polychlorinated biphenyls and the prevalence of diabetes in the Saku Control Obesity Program. Endocrine journal.
15. Nakade M, Aiba N, Suda N, Morita A, Miyachi M, et al. (2012) Behavioral change during weight loss program and one-year follow-up: Saku Control Obesity Program (SCOP) in Japan. Asia Pac J Clin Nutr 21: 22-34.
16. White WB, Anwar YA, (2001) Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 6: 107-110.
17. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, et al. (2012) International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of Diabetes Investigation 3: 39-40.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
19. DeFronzo RA, Matsuda M, (2010) Reduced time points to calculate the composite index. Diabetes Care 33: e93.
20. Wallace TM, Levy JC, Matthews DR, (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495.
21. Kosaka K, Hagura R, Kuzuya T, (1977) Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26: 944-952.
22. Yoneda H, Ikegami H, Yamamoto Y, Yamato E, Cha T, et al. (1992) Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 15: 1517-1521.
23. DeFronzo RA, Matsuda M, (2010) Reduced time points to calculate the composite index. Diabetes Care 33: e93.
24. Wareham NJ, Phillips DI, Byrne CD, Hales CN, (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12: 931.
25. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
26. Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, et al. (2004) Effects of weight loss in overweight/obese individuals and long-term lipid outcomes-a systematic review. Obes Rev 5: 43-50.
27. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.
28. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H, (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 13: S109-119.
29. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, et al. (1997) Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 20: 1562-1568.